lamivudine has been researched along with Chromosome Deletion in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirashima, N; Ide, T; Ito, K; Mizokami, M; Orito, E; Sata, M; Tanaka, Y; Yeo, AE | 1 |
1 other study(ies) available for lamivudine and Chromosome Deletion
| Article | Year |
|---|---|
Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection.
Topics: Adult; Aged; Amino Acid Sequence; Antiviral Agents; Chromosome Deletion; DNA Mutational Analysis; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Viral; Female; Hepacivirus; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Protein Precursors; Regression Analysis | 2004 |